Author Archives: Scalper1

Gilead Leads 3 Drug Stocks With Top Fundamentals

Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN) and Alexion Pharmaceuticals (ALXN) are the focus of the Screen of the Day: Top Fundamentals. Companies with top fundamentals are highly rated by IBD and have 3-year sales and earnings growth rates of at least 25%. Gilead broadens fight against HCV 2016 might not bring the huge drug launches seen in previous years. But Gilead Sciences, known for its highly effective, highly priced hepatitis C

Will Solar Stocks Face Rough 2016 For Installations?

U.S. solar installations are expected to grow 10% in 2016, down sharply from prior forecasts for a 40%-50% boom, but companies such as SolarCity (SCTY), Sunrun (RUN) and SunPower (SPWR) are celebrating. Why? The reason for the forecast cut is that in a last-minute accord among politicians in December, Congress extended the Investment Tax Credit (ITC) on solar installations through 2023 in exchange for lifting a 40-year ban on U.S. oil exports. The

BlackBerry Priv Expanding to Verizon, T-Mobile, Sprint

BlackBerry BBRY CEO John Chen announced today that the company’s new “Priv” phone will be heading to Verizon VZ , T Mobile TMUS , and Sprint S . Blackberry originally entered into a 60 day exclusivity agreement with AT&T